Skip to main content
Top
Published in: Rheumatology International 11/2008

01-09-2008 | Case Report

Autoantibodies to alfa-fodrin in patients with Hashimoto thyroiditis and Sjögren’s syndrome: possible markers for a common secretory disorder

Authors: Antonia Szanto, Istvan Csipo, Ildiko Horvath, Edit Biro, Peter Szodoray, Margit Zeher

Published in: Rheumatology International | Issue 11/2008

Login to get access

Abstract

Presence of autoantibodies to alfa-fodrin was investigated in patients with Sjögren’s syndrome (n = 61), Hashimoto thyroiditis (n = 27), Sjögren’s syndrome associated with Hashimoto thyroiditis (n = 31) and in healthy persons (n = 77). In each group, level of alfa-fodrin antibodies was higher than in the controls. There was no significant difference in their presence either between patients with Hashimoto thyroiditis with or without Sjögren’s syndrome, or—in IgA isotype—between Sjögren’s and Hashimoto thyroiditis patients. Correlation was found between the level of IgG alfa-fodrin and anti-thyroglobulin antibodies. Based on these findings, fodrin can be associated with both endocrine and exocrine glandular secretion. Antibodies to alfa-fodrin might have a role in the pathogenesis of Hashimoto thyroiditis concerning the “final common effectory pathway”, secretion. Alfa-fodrin antibodies can be good markers of secretory disorders. Assessment of these autoantibodies might help the diagnosis and follow-up of patients with impaired secretory capability of not only autoimmune origin.
Literature
1.
go back to reference Jonsson R, Bowman SJ, Gordon TP (2005) Sjögren’s syndrome. In: Koopman WJ, Moreland LW (eds) Arthritis and allied conditions. Textbook of rheumatology. Lippincott Williams and Wilkins, Philadelphia, pp 1681–1705 Jonsson R, Bowman SJ, Gordon TP (2005) Sjögren’s syndrome. In: Koopman WJ, Moreland LW (eds) Arthritis and allied conditions. Textbook of rheumatology. Lippincott Williams and Wilkins, Philadelphia, pp 1681–1705
2.
go back to reference Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y (1997) Identification of α-fodrin as a candidate autoantigen in primary Sjögren’s syndrome. Science 276:604–607PubMedCrossRef Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y (1997) Identification of α-fodrin as a candidate autoantigen in primary Sjögren’s syndrome. Science 276:604–607PubMedCrossRef
3.
go back to reference Perrin D, Aunis D (1985) Reorganization of α-fodrin induced by stimulation in secretory cells. Nature 315:589–592PubMedCrossRef Perrin D, Aunis D (1985) Reorganization of α-fodrin induced by stimulation in secretory cells. Nature 315:589–592PubMedCrossRef
4.
go back to reference Nakano M, Nogami S, Sato S, Terano A, Shirataki H (2001) Interaction of syntaxin with α-fodrin, a major component of the submembranous cytosceleton. Biochem Biophys Res Commun 288:468–475PubMedCrossRef Nakano M, Nogami S, Sato S, Terano A, Shirataki H (2001) Interaction of syntaxin with α-fodrin, a major component of the submembranous cytosceleton. Biochem Biophys Res Commun 288:468–475PubMedCrossRef
5.
go back to reference van Blokland SCA, Versnel MA (2002) Pathogenesis of Sjögren’s syndrome: characteristics of different mouse models for autoimmune exocrinopathy. Clin Immunol 103:111–124PubMedCrossRef van Blokland SCA, Versnel MA (2002) Pathogenesis of Sjögren’s syndrome: characteristics of different mouse models for autoimmune exocrinopathy. Clin Immunol 103:111–124PubMedCrossRef
6.
go back to reference Sordet C, Gottenberg JE, Goetz J, Bengoufa D, Humbel R-L, Mariette X, Sibilia J (2005) Anti-α-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren’s syndrome. Ann Rheum Dis 64:1244–1245 LetterPubMedCrossRef Sordet C, Gottenberg JE, Goetz J, Bengoufa D, Humbel R-L, Mariette X, Sibilia J (2005) Anti-α-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren’s syndrome. Ann Rheum Dis 64:1244–1245 LetterPubMedCrossRef
7.
go back to reference Miyazaki K, Takeda N, Ishimaru N, Omotehara F, Arakaki R, Hayashi Y (2005) Analysis of in vivo role of α-fodrin autoantigen in primary Sjögren’s syndrome. Am J Pathol 167:1051–1059PubMed Miyazaki K, Takeda N, Ishimaru N, Omotehara F, Arakaki R, Hayashi Y (2005) Analysis of in vivo role of α-fodrin autoantigen in primary Sjögren’s syndrome. Am J Pathol 167:1051–1059PubMed
8.
go back to reference Alnemri ES, Livingston DJ, Nicholson DW, Salvensen G, Thornberry NA, Wong WW, Yuan J (1996) Human ICE/CED-3 protease nomenclature. Cell 87:171PubMedCrossRef Alnemri ES, Livingston DJ, Nicholson DW, Salvensen G, Thornberry NA, Wong WW, Yuan J (1996) Human ICE/CED-3 protease nomenclature. Cell 87:171PubMedCrossRef
9.
go back to reference Martin SD, O’Brien GA, Nishioka WK, McGahon AJ, Mahboubi A, Saido TV, Green DR (1995) Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem 270:6425–6428PubMedCrossRef Martin SD, O’Brien GA, Nishioka WK, McGahon AJ, Mahboubi A, Saido TV, Green DR (1995) Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem 270:6425–6428PubMedCrossRef
10.
go back to reference Martin SD, Finucane DM, Amarante-Mendes DP, O’Brien GA, Green DR (1996) Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem 271:28753–28756PubMedCrossRef Martin SD, Finucane DM, Amarante-Mendes DP, O’Brien GA, Green DR (1996) Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem 271:28753–28756PubMedCrossRef
11.
go back to reference Vanags DM, Pörn-Ares I, Coppolaa S, Burgess DH, Orrenius S (1996) Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 271:31075–31085PubMedCrossRef Vanags DM, Pörn-Ares I, Coppolaa S, Burgess DH, Orrenius S (1996) Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 271:31075–31085PubMedCrossRef
12.
go back to reference Zandbelt MM, Vogelzanks J, van de Putte LBA, van Venrooij WJ, van den Hoogen FHJ (2004) Anti-α-fodrin antibodies do not add much to the diagnosis of Sjögren’s syndrome. Arthritis Res Ther 6:R33–R38PubMedCrossRef Zandbelt MM, Vogelzanks J, van de Putte LBA, van Venrooij WJ, van den Hoogen FHJ (2004) Anti-α-fodrin antibodies do not add much to the diagnosis of Sjögren’s syndrome. Arthritis Res Ther 6:R33–R38PubMedCrossRef
13.
go back to reference Kobayashi I, Kawamura N, Okano M, Shikano T, Mizumoto M, Hayashi Y, Kobayashi K (2001) Anti-α-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren’s syndrome. J Rheumatol 28:363–365PubMed Kobayashi I, Kawamura N, Okano M, Shikano T, Mizumoto M, Hayashi Y, Kobayashi K (2001) Anti-α-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren’s syndrome. J Rheumatol 28:363–365PubMed
14.
go back to reference Takahashi K, Tatsuzawa O, Yanagi K, Hayashi Y, Takahashi H (2000) Alpha-fodrin auto-antibody in Sjögren syndrome and other auto-immune diseases in childhood. Eur J Pediatr 160:520–521CrossRef Takahashi K, Tatsuzawa O, Yanagi K, Hayashi Y, Takahashi H (2000) Alpha-fodrin auto-antibody in Sjögren syndrome and other auto-immune diseases in childhood. Eur J Pediatr 160:520–521CrossRef
15.
go back to reference Witte T, Matthias T, Arnett FC, Peter HH, Hartung K, Sachse C, Wigand R, Braner A, Kalden JR, Lakomek HJ, Schmidt RE (2000) IgA and IgG autoanatibodies against α-fodrin as markers for Sjögren’s syndrome. J Rheumatol 27:2617–2620PubMed Witte T, Matthias T, Arnett FC, Peter HH, Hartung K, Sachse C, Wigand R, Braner A, Kalden JR, Lakomek HJ, Schmidt RE (2000) IgA and IgG autoanatibodies against α-fodrin as markers for Sjögren’s syndrome. J Rheumatol 27:2617–2620PubMed
16.
go back to reference Horiuchi A, Kawa S, Hamano H, Hayashi Y, Kiyosawa K (2002) Does a lack of reactivity to alpha-fodrin indicate the existence of primary autoimmune pancreatitis? Am J Gastroenterol 97:1275–1277PubMed Horiuchi A, Kawa S, Hamano H, Hayashi Y, Kiyosawa K (2002) Does a lack of reactivity to alpha-fodrin indicate the existence of primary autoimmune pancreatitis? Am J Gastroenterol 97:1275–1277PubMed
17.
go back to reference Watanabe T, Tsuchida T, Kanda N, Mori K, Hayashi Y, Tamaki K (1999) Anti-α-fodrin antibodies in Sjögren syndrome and lupus erythematosus. Arch Dermatol 135:535–539PubMedCrossRef Watanabe T, Tsuchida T, Kanda N, Mori K, Hayashi Y, Tamaki K (1999) Anti-α-fodrin antibodies in Sjögren syndrome and lupus erythematosus. Arch Dermatol 135:535–539PubMedCrossRef
18.
go back to reference D’Arbonneau F, Ansart S, Le Berrre R, Dueymes M, Youinou P, Pennec YL (2003) Thyroid dysfunction in primary Sjogren’s syndrome: a long-term followup study. Arthritis Rheum 49:804–809PubMedCrossRef D’Arbonneau F, Ansart S, Le Berrre R, Dueymes M, Youinou P, Pennec YL (2003) Thyroid dysfunction in primary Sjogren’s syndrome: a long-term followup study. Arthritis Rheum 49:804–809PubMedCrossRef
19.
go back to reference Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) European study group on classification criteria for Sjogren’s syndrome: classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558PubMedCrossRef Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) European study group on classification criteria for Sjogren’s syndrome: classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558PubMedCrossRef
20.
go back to reference Lawind MF, Alyasky A, Elwan NM, Mourad H, Al-Bendary A (2004) Alpha-fodrin antibodies are reliable diagnostic markers for juvenile and adult Sjogren’s syndrome. Egypt J Immunol 11:75–81PubMed Lawind MF, Alyasky A, Elwan NM, Mourad H, Al-Bendary A (2004) Alpha-fodrin antibodies are reliable diagnostic markers for juvenile and adult Sjogren’s syndrome. Egypt J Immunol 11:75–81PubMed
21.
go back to reference Szanto A, Csipo I, Zeher M (2005) Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjogren’s syndrome. J Rheumatol 32:197–198 Author replyPubMed Szanto A, Csipo I, Zeher M (2005) Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjogren’s syndrome. J Rheumatol 32:197–198 Author replyPubMed
22.
go back to reference Fox RI, Törnwall J, Maruyama T, Störn M (1998) Evolving concepts of diagnosis, pathogenesis, and therapy of Sjögren’s syndrome. Curr Opin Rheumatol 10:446–456PubMedCrossRef Fox RI, Törnwall J, Maruyama T, Störn M (1998) Evolving concepts of diagnosis, pathogenesis, and therapy of Sjögren’s syndrome. Curr Opin Rheumatol 10:446–456PubMedCrossRef
23.
go back to reference Aichinger G, Fill H, Wick G (1985) In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis. Lab Invest 52:132–140PubMed Aichinger G, Fill H, Wick G (1985) In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis. Lab Invest 52:132–140PubMed
24.
go back to reference McLachlan SM, Rapoport B (1992) The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease. Endocr Rev 13:192–206PubMedCrossRef McLachlan SM, Rapoport B (1992) The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease. Endocr Rev 13:192–206PubMedCrossRef
25.
go back to reference Liblau RS, Singer SM, McDevitt HO (1995) Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34–38PubMedCrossRef Liblau RS, Singer SM, McDevitt HO (1995) Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34–38PubMedCrossRef
26.
go back to reference Fox RI (1996) Sjogren’s syndrome: immunobiology of exocrine gland dysfunction. Adv Dent Res 10:35–40PubMedCrossRef Fox RI (1996) Sjogren’s syndrome: immunobiology of exocrine gland dysfunction. Adv Dent Res 10:35–40PubMedCrossRef
27.
go back to reference Witte T, Bierwirth J, Schmidt RE, Matthias T (2006) Antibodies against α-fodrin are associated with dry eyes and mouth in the general population. J Rheumatol 33:1713PubMed Witte T, Bierwirth J, Schmidt RE, Matthias T (2006) Antibodies against α-fodrin are associated with dry eyes and mouth in the general population. J Rheumatol 33:1713PubMed
28.
go back to reference Ishimura K, Senda T, Kitajima K, Fujita H, Fujio Y, Sobue K (1987) Immunocytochemical localization of calspectin (a non-erythroid spectrin-like protein) in thyroid glands of normal and TSH-treated rats. Histochemistry 86:537–539PubMedCrossRef Ishimura K, Senda T, Kitajima K, Fujita H, Fujio Y, Sobue K (1987) Immunocytochemical localization of calspectin (a non-erythroid spectrin-like protein) in thyroid glands of normal and TSH-treated rats. Histochemistry 86:537–539PubMedCrossRef
29.
go back to reference Gabrion JB, Barriere H, Nguyen Than Dao B, Chambard M, Mauchamp J, Regnouf F, Pradel LA (1990) Abscence of fodrin (spectrin-like protein) under the pseudopod membrane in stimulated thyroid cells. Eur J Cell Biol 52:282–290PubMed Gabrion JB, Barriere H, Nguyen Than Dao B, Chambard M, Mauchamp J, Regnouf F, Pradel LA (1990) Abscence of fodrin (spectrin-like protein) under the pseudopod membrane in stimulated thyroid cells. Eur J Cell Biol 52:282–290PubMed
Metadata
Title
Autoantibodies to alfa-fodrin in patients with Hashimoto thyroiditis and Sjögren’s syndrome: possible markers for a common secretory disorder
Authors
Antonia Szanto
Istvan Csipo
Ildiko Horvath
Edit Biro
Peter Szodoray
Margit Zeher
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0582-z

Other articles of this Issue 11/2008

Rheumatology International 11/2008 Go to the issue